On the other hand, differentially expressed genes and enriched signaling pathways were analyzed in two groups of breast cancer patients divided according to SMS, PAFAH1B2, and PDK3 expression from TCGA dataset (group of 3 target genes high expression, n = 166; group of 3 target genes low expression, n = 197). This evidence concerns the gene PAFAH1B2 and breast cancer.